Biopharma-Focused Jeito Wraps 2nd Fund With $1.2B In Tow
Biopharmaceutical-focused private equity shop Jeito Capital, advised by Goodwin Procter LLP, on Wednesday announced that it closed its second fund above target after raising more than €1 billion ($1.2 billion) from...To view the full article, register now.
Already a subscriber? Click here to view full article